MedPath

Free-living assessment of Cardiorespiratory Fitness.

Conditions
niet-klinisch onderzoek met gezonde proefpersonen
not applicable
Registration Number
NL-OMON37152
Lead Sponsor
Philips Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Men and women
Aged between 18-45 years
Body mass index between 18.5-27 kg/m2
Informed consent by the participants

Exclusion Criteria

Subjects with a chronic disease, such as chronic obstructive pulmonary disease, diabetes, cardiovascular disease or any condition known to affect normal cardiovascular functioning. Any musculoskeletal condition that would prevent the subject from perfoming the exercise protocol.
Subjects taking medication, except for oral contraceptives.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>• Maximal aerobic capacity (VO2max) as a measure of cardiorespiratory fitness<br /><br>as assessed by an incremental test on a bicycle ergometer.<br /><br>• Maximal aerobic capacity (VO2max) as a measure of cardiorespiratory fitness<br /><br>as estimated by a combination of heart rate recording and movement registration<br /><br>(accelerometry) in daily life.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>maximal heart rate<br /><br>resting heart rate<br /><br>heart rate recovery<br /><br>daily physical activity (accelerometer counts)<br /><br>body composition (% fat mass and fat-free mass)</p><br>
© Copyright 2025. All Rights Reserved by MedPath